By Tom Fish ( October 14, 2022, 5:15 PM BST) -- Arix Bioscience PLC subsidiary Imara Inc. and Enliven Therapeutics Inc. said on Friday they have agreed to merge in an all-stock deal to create a pharmaceutical company valued at approximately $300 million, according to a London Stock Exchange announcement....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.